TrialThe Lancet. Neurology2023

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.

James F Howard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.